Aquestive Therapeutics(us:AQST)
3.58
-1.92%
Updated on 2024-12-23
Open:3.65
Close:3.58
High:3.66
Low:3.52
Pre Close:3.65
Volume:523459.00
Amount:1.87M
Turnover:0.57%
Shares:91.18M
MarketCap:325.96M
| Date | Total | Total Shares | Total Ratio | New | Increased | Decreased |
|---|---|---|---|---|---|---|
| 2024-06-30 | 124 | 42358135 | 46.52% | 27 | 31 | 54 |
| 2024-03-31 | 107 | 41494848 | 45.86% | 51 | 23 | 24 |
| 2023-12-31 | 64 | 23788793 | 34.71% | 15 | 17 | 20 |
| 2023-09-30 | 60 | 22850373 | 34.24% | 7 | 12 | 25 |
| 2023-06-30 | 60 | 19076504 | 30.96% | 23 | 19 | 9 |
| 2023-03-31 | 43 | 14959549 | 26.75% | 8 | 7 | 14 |
| 2022-12-31 | 48 | 14924589 | 27.22% | 3 | 5 | 24 |
| 2022-09-30 | 52 | 15895380 | 29.52% | 6 | 11 | 20 |
| date | orgName | total | ratio | changeShares | changeRatio |
|---|---|---|---|---|---|
| 2024-03-31 | Bratton Capital Management, L.P. | 9810958 | 10.84% | 0 | |
| 2024-03-31 | Vr Adviser, Llc | 5555555 | 6.14% | 5555555 | |
| 2024-03-31 | Vanguard Group Inc | 3242571 | 3.58% | 1353518 | 71.65% |
| 2024-03-31 | Franklin Resources Inc | 2220000 | 2.45% | 2220000 | |
| 2024-03-31 | Laurion Capital Management Lp | 1545300 | 1.71% | 1545300 | |
| 2024-03-31 | Renaissance Technologies Llc | 1375800 | 1.52% | 104300 | 8.20% |
| 2024-03-31 | Blackrock Inc. | 1344876 | 1.49% | 866857 | 181.34% |
| 2024-03-31 | Monashee Investment Management Llc | 1000000 | 1.11% | 1000000 | |
| 2024-03-31 | Invesco Ltd. | 897512 | 0.99% | 897512 | |
| 2024-03-31 | Blue Owl Capital Holdings Lp | 875000 | 0.97% | 875000 |
About
Aquestive Therapeutics, Inc. engages in the identifying, developing, and commercializing differentiated products to address unmet medical needs and to solve patients’ therapeutic problems. Its product pipeline include Libervant, AQST-108, AQST-305, Suboxone and Zuplenz. The company was founded in January 2004 and is headquartered in Warren, NJ.
Address:30 Technology Drive
Website:http://www.aquestive.com
Market Movers